|
Office Locations:
|
401 South Cedar Street
Little Rock, AR 72205
Phone: 501-686-6696
Fax: 501-686-8501
| | |
|
|
|
Life Sciences & Healthcare
Medical Device
|
|
|
UAMS Arkansas BioVentures and its Technology Licensing Office (TLO) were established as a formal outgrowth of the University of Arkansas for Medical Sciences' (UAMS) interest in translating its research into products that benefit human health. The UAMS College of Medicine established UAMS BioVentures in 1997 to maximize global, industrial interaction with the University of Arkansas faculty, as well as to facilitate technology transfer, the creation of startup companies that are based on UAMS technology invention disclosure, and contributions to Arkansas' economic development. UAMS' primary missions is to translate publicly funded research into products that benefit human healthcare and convert Arkansas' medical and biotechnology research into new companies and high wage jobs for Arkansans. BioVentures offers the UAMS client companies access to many University resources, both at UAMS and at the University of Arkansas at Little Rock (UALR), and a 16,500 square foot new business incubator facility. This facility also houses GMP (Good Manufacturing Practice) laboratories and production space that has been qualified to support the development of clinical research. UAMS is the state’s largest basic and applied research institution, with a total budget of $1.3 billion and more than $100 million in annual research funding.
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
COMPANY STAGE | REVENUE |
Venture Capital | |
Seed Stage (includes "pre-seed," or concept stage) | No Revenue |
Early Stage | Minimal Revenue |
Growth Stage (also called Mid-stage) | $2M-$7M |
Expansion Stage (also called Late-stage) | $7M and greater |
Private Equity | |
Lower Middle Market | $10M-$249M |
Middle Market | $250M-$499M |
Upper Middle Market | $500M-$1B |
Large Cap | >$1B |
|
|
|
|